Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems
RSC Pharmaceutics · 2025 · 2 (5) · 1050-1077
DOI: 10.1039/d5pm00068h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Sourabh Kundu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, Science and Engineering Research Board, Indian Council of Medical Research.
Abstract (Originalsprache)
This article discusses emerging ophthalmic drug delivery systems such as nanoparticles and stimuli-responsive systems for non-invasive or minimally invasive glaucoma therapy.
Förderung
- Department of Science and Technology, Ministry of Science and Technology
- Science and Engineering Research Board
- Indian Council of Medical Research
Zitieren
APA
Kundu, S., Kumari, G., & Srinivasarao, D. A. (2025). Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems. RSC Pharmaceutics, 2(5), 1050-1077. https://doi.org/10.1039/d5pm00068h
Vancouver
Kundu S, Kumari G, Srinivasarao DA. Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems. RSC Pharmaceutics. 2025;2(5):1050-1077. doi:10.1039/d5pm00068h
BibTeX
@article{Kundu2025,
author = {Kundu, Sourabh and Kumari, Gitika and Srinivasarao, Dadi A.},
title = {Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems},
journal = {RSC Pharmaceutics},
year = {2025},
volume = {2},
number = {5},
pages = {1050--1077},
doi = {10.1039/d5pm00068h}
}
EUVIMED